Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-01

Clinical Trial Update: Impact of a Coordinated Dietetic-adapted Physical Activity Program on the Percentage of Lean Body Mass in Adults With Cystic Fibrosis Treated With Elexacaftor-Tezacaftor-Ivacaftor: Multicentre Randomised Controlled Trial [NA]

View source ↗

Summary

A multicenter randomized trial is evaluating whether a dietetic-adapted physical activity program can influence lean body mass in adults with cystic fibrosis wh…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TRIKAFTA (ELEXACAFTOR, TEZACAFTOR, AND IVACAFTOR)

Snippet

Sponsor: University Hospital, Tours | Conditions: Cystic Fibrosis | NA | Status: RECRUITING